nach oben

Network Modeling Analysis in Health Informatics and Bioinformatics

Erschienen in:

01.12.2021 | Original Article

Identification of potential Parkinson’s disease biomarkers using computational biology approaches

verfasst von: Hussain Ahmed Chowdhury, Pankaj Barah, Dhruba Kumar Bhattacharyya, Jugal Kumar Kalita

Erschienen in: Network Modeling Analysis in Health Informatics and Bioinformatics | Ausgabe 1/2021

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

Parkinson’s disease (PD) is one of the most common neurodegenerative disorders. This aging-related disease occurs due to the degenerative loss of tissue or cellular functions in the brain and due to genetic and epigenetic effects. This study was conducted on an RNA-seq dataset of PD collected from BA9 tissues to get insights to PD. A few RNA-seq based transcriptomics studies on PD are available. However, most of these studies are limited to differential expression analysis, i.e., individual gene-based analysis that ignores interactions and associations among genes to establish the association with the disease. Here, we initially identify differentially expressed genes and then construct a co-expression network on detected genes to identify modules. Module preservation analysis is carried out to find the non-preserved modules. We identify a non-preserved module with 73 (70 are annotated) genes. Differential connectivity analysis, topological analysis, and functional enrichment analysis are performed to find the initial set of interesting genes. Our finding is that 42 (60%) genes are significantly enriched in pathways, biological processes, or molecular functions, and they are topologically interesting. Among these genes, 19 can be linked to the PD based on evidence from literature. They are considered as biomarkers for PD. From the remaining 23 genes, 11 are expressed in brain region. Therefore, these genes may be further explored to understand their roles in PD and can be considered as potential biomarkers.

Vorheriger Artikel A compressive mathematical model including an eclipse stage of infected cells to study the impact of stem cells transplantation on one HIV1 patient

Nächster Artikel An integrative docking and simulation-based approach towards the development of epitope-based vaccine against enterotoxigenic Escherichia coli

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 340 Zeitschriften

aus folgenden Fachgebieten:

Bauwesen + Immobilien
Business IT + Informatik
Finance + Banking
Management + Führung
Marketing + Vertrieb
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Nur mit Berechtigung zugänglich

http://llama.mshri.on.ca/funcassociate/.

https://www.psb.ugent.be/cbd/papers/BiNGO/Home.html.

https://www.genecards.org/.

Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R (2004) Mutations in the glucocerebrosidase gene and Parkinson’s disease in Ashkenazi Jews. N Engl J Med 351(19):1972–1977CrossRef

Al-Aamri A, Taha K, Al-Hammadi Y, Maalouf M, Homouz D (2019) Analyzing a co-occurrence gene-interaction network to identify disease-gene association. BMC Bioinform 20(1):70CrossRef

Anders S, Huber W (2010) Differential expression analysis for sequence count data. Genom Biol 11(10):R106CrossRef

Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT et al (2000) Gene ontology: tool for the unification of biology. Nat Genet 25(1):25CrossRef

Auer PL, Doerge RW et al (2011) A two-stage Poisson model for testing RNA-seq data. Stat Appl Genet Mol Biol 10(1):1–26MathSciNetMATHCrossRef

Barabási AL, Albert R (1999) Emergence of scaling in random networks. Science 286(5439):509–512MathSciNetMATHCrossRef

Barabasi AL, Oltvai ZN (2004) Network biology: understanding the cell’s functional organization. Nat Rev Genet 5(2):101CrossRef

Barbiero JK, Santiago R, Tonin FS, Boschen S, da Silva LM, de Paula Werner MF, da Cunha C, Lima MM, Vital MA (2014) Ppar-\(\alpha\) agonist fenofibrate protects against the damaging effects of mptp in a rat model of parkinson’s disease. Prog Neuro Psychopharm Biolog Psychiatry 53:35–44CrossRef

Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodol): 289–300

Borrageiro G, Haylett W, Seedat S, Kuivaniemi H, Bardien S (2018) A review of genome-wide transcriptomics studies in Parkinson’s disease. Eur J Neurosci 47(1):1–16CrossRef

Bowen RL, Atwood CS (2004) Living and dying for sex. Gerontology 50(5):265–290CrossRef

Braak H, Del Tredici K, Rüb U, De Vos RA, Steur ENJ, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24(2):197–211CrossRef

Chatterjee A, Singh KK (2001) Uracil-DNA glycosylase-deficient yeast exhibit a mitochondrial mutator phenotype. Nucleic Acids Res 29(24):4935–4940CrossRef

Chaturvedi RK, Beal MF (2008) PPAR: a therapeutic target in Parkinson’s disease. J Neurochem 106(2):506–518CrossRef

Chen SY, Feng Z, Yi X (2017) A general introduction to adjustment for multiple comparisons. J Thora Dis 9(6):1725CrossRef

Cheng D, Jenner AM, Shui G, Cheong WF, Mitchell TW, Nealon JR, Kim WS, McCann H, Wenk MR, Halliday GM et al (2011) Lipid pathway alterations in Parkinson’s disease primary visual cortex. PLoS One 6(2):e17299CrossRef

Chowdhury HA, Bhattacharyya DK et al (2020a) (Differential) Co-expression analysis of gene expression: a survey of best practices. IEEE/ACM TCBB 17(4):1154–1173

Chowdhury HA, Bhattacharyya DK et al (2020b) Differential expression analysis of RNA-seq reads: overview, taxonomy, and tools. IEEE/ACM TCBB 17(2):566–586

Collado-Torres L, Nellore A, Kammers K, Ellis SE, Taub MA, Hansen KD, Jaffe AE, Langmead B, Leek JT (2017) Reproducible RNA-seq analysis using recount2. Nat Biotechnol 35(4):319CrossRef

Costa-Silva J, Domingues D, Lopes FM (2017) RNA-Seq differential expression analysis: an extended review and a software tool. PloS One 12(12):e0190152CrossRef

De Lau LM, Breteler MM (2006) Epidemiology of Parkinson’s disease. Lancet Neurol 5(6):525–535CrossRef

Di Fonzo A, Chien H, Socal M, Giraudo S, Tassorelli C, Iliceto G, Fabbrini G, Marconi R, Fincati E, Abbruzzese G et al (2007) ATP13A2 missense mutations in juvenile Parkinsonism and young onset Parkinson disease. Neurology 68(19):1557–1562CrossRef

Dick FD, De Palma G, Ahmadi A, Osborne A, Scott NW, Prescott GJ, Bennett J, Semple S, Dick S, Mozzoni P et al (2007) Gene-environment interactions in parkinsonism and Parkinson’s disease: the geoparkinson study. Occup Environ Med 64(10):673–680CrossRef

Dumitriu A, Latourelle JC, Hadzi TC, Pankratz N, Garza D, Miller JP, Vance JM, Foroud T, Beach TG, Myers RH (2012) Gene expression profiles in parkinson disease prefrontal cortex implicate foxo1 and genes under its transcriptional regulation. PLoS Genet 8(6):e1002794CrossRef

Dumitriu A, Golji J, Labadorf AT, Gao B, Beach TG, Myers RH, Longo KA, Latourelle JC (2015) Integrative analyses of proteomics and rna transcriptomics implicate mitochondrial processes, protein folding pathways and gwas loci in parkinson disease. BMC Med Geno 9(1):5CrossRef

Eder T, Grebien F, Rattei T (2016) NVT: a fast and simple tool for the assessment of RNA-seq normalization strategies. Bioinformatics 32(23):3682–3684

Farin FM, Janssen P, Quigley S, Abbott D, Hassett C, Smith-Weller T, Franklin GM, Swanson PD, Longstreth W Jr, Omiecinski CJ et al (2001) Genetic polymorphisms of microsomal and soluble epoxide hydrolase and the risk of Parkinson’s disease. Pharmacogenet Genom 11(8):703–708CrossRef

Filloux C, Cédric M, Romain P et al (2014) An integrative method to normalize RNA-Seq data. BMC Bioinform 15(1):188CrossRef

Filteau M, Pavey SA, St-Cyr J et al (2013) Gene coexpression networks reveal key drivers of phenotypic divergence in lake whitefish. Mol Biol Evolut 30(6):1384–1396CrossRef

Finotello F, Di Camillo B (2015) Measuring differential gene expression with RNA-seq: challenges and strategies for data analysis. Brief Funct Genom 14(2):130–142CrossRef

Fischer D, Hauk TG, Müller A, Thanos S (2008) Crystallins of the \(\beta\)/\(\gamma\)-superfamily mimic the effects of lens injury and promote axon regeneration. Mol Cell Neurosci 37(3):471–479CrossRef

Geisler S, Holmström KM, Skujat D, Fiesel FC, Rothfuss OC, Kahle PJ, Springer W (2010) PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol 12(2):119CrossRef

Gerard M, Deleersnijder A, Daniëls V, Schreurs S, Munck S, Reumers V, Pottel H, Engelborghs Y, Van den Haute C, Taymans JM et al (2010) Inhibition of fk506 binding proteins reduces \(\alpha\)-synuclein aggregation and parkinson’s disease-like pathology. J Neurosci 30(7):2454–2463CrossRef

Hadzi TC, Hendricks AE, Latourelle JC, Lunetta KL, Cupples LA, Gillis T, Mysore JS, Gusella JF, MacDonald ME, Myers RH et al (2012) Assessment of cortical and striatal involvement in 523 Huntington disease brains. Neurology 79(16):1708–1715CrossRef

Halliday G, Del Tredici K, Braak H (2006) Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson’s disease. In: Parkinson’s Disease and Related Disorders, Springer, pp 99–103

Harvey B, Mark A, Chou J, Chen G, Hoffer B, Wang Y (2004) Neurotrophic effects of bone morphogenetic protein-7 in a rat model of Parkinson’s disease. Brain Res 1022(1–2):88–95CrossRef

Hawkes C, Shephard B, Daniel S (1999) Is Parkinson’s disease a primary olfactory disorder? QJM Int J Med 92(8):473–480

Henderson-Smith A, Corneveaux JJ, De Both M, Cuyugan L, Liang WS, Huentelman M, Adler C, Driver-Dunckley E, Beach TG, Dunckley TL (2016) Next-generation profiling to identify the molecular etiology of Parkinson dementia. Neurol Genet 2(3):e75CrossRef

Hossein-Nezhad A, Fatemi RP, Ahmad R, Peskind ER, Zabetian CP, Hu SC, Shi M, Wahlestedt C, Zhang J, Faghihi MA (2016) Transcriptomic profiling of extracellular RNAs present in cerebrospinal fluid identifies differentially expressed transcripts in Parkinson’s disease. J Parkinson’s Dis 6(1):109–117CrossRef

Hu M, Cooper J, Beamish R, Jones E, Butterworth R, Catterall L, Ben-Shlomo Y (2011) How well do we recognise non-motor symptoms in a British Parkinson’s disease population? J Neurol 258(8):1513–1517CrossRef

Huang DW, Sherman BT, Lempicki RA (2008) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37(1):1–13CrossRef

Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protocols 4(1):44–57CrossRef

Hwang O (2013) Role of oxidative stress in Parkinson’s disease. Exp Neurobiol 22(1):11–17CrossRef

Infante J, Prieto C, Sierra M, Sánchez-Juan P, González-Aramburu I, Sánchez-Quintana C, Berciano J, Combarros O, Sainz J (2015) Identification of candidate genes for Parkinson’s disease through blood transcriptome analysis in LRRK2-G2019S carriers, idiopathic cases, and controls. Neurobiol Aging 36(2):1105–1109CrossRef

Infante J, Prieto C, Sierra M, Sánchez-Juan P, González-Aramburu I, Sánchez-Quintana C, Berciano J, Combarros O, Sainz J (2016) Comparative blood transcriptome analysis in idiopathic and LRRK2 G2019S-associated Parkinson’s disease. Neurobiol Aging 38:214-e1CrossRef

Jiang H, Ren Y, Yuen EY, Zhong P, Ghaedi M, Hu Z, Azabdaftari G, Nakaso K, Yan Z, Feng J (2012) Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells. Nat Commun 3:668CrossRef

Kadonaga JT (2004) Regulation of rna polymerase ii transcription by sequence-specific dna binding factors. Cell 116(2):247–257CrossRef

Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392(6676):605CrossRef

Kõks S, Overall RW, Ivask M, Soomets U, Guha M, Vasar E, Fernandes C, Schalkwyk LC (2013) Silencing of the WFS1 gene in HEK cells induces pathways related to neurodegeneration and mitochondrial damage. Physiol Genom 45(5):182–190CrossRef

Kori M, Aydın B, Unal S, Arga KY, Kazan D (2016) Metabolic biomarkers and neurodegeneration: a pathway enrichment analysis of alzheimer’s disease, parkinson’s disease, and amyotrophic lateral sclerosis. Omics 20(11):645–661CrossRef

Kurz A, Double KL, Lastres-Becker I, Tozzi A, Tantucci M, Bockhart V, Bonin M, García-Arencibia M, Nuber S, Schlaudraff F et al (2010) A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice. PloS One 5(7):e11464CrossRef

Kvam VM, Liu P, Si Y (2012) A comparison of statistical methods for detecting differentially expressed genes from RNA-seq data. Am J Bot 99(2):248–256CrossRef

Labadorf A, Choi SH, Myers RH (2018) Evidence for a pan-neurodegenerative disease response in Huntington’s and Parkinson’s disease expression profiles. Front Mol Neurosci 10:430CrossRef

Langfelder P, Horvath S (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinform 9(1):559CrossRef

Langfelder P, Luo R et al (2011) Is my network module preserved and reproducible? PLoS Comput Biol 7(1):e1001057MathSciNetCrossRef

Lesage S, Brice A (2009) Parkinson’s disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet 18(R1):R48–R59CrossRef

Lesnick TG, Papapetropoulos S, Mash DC, Ffrench-Mullen J, Shehadeh L, De Andrade M, Henley JR, Rocca WA, Ahlskog JE, Maraganore DM (2007) A genomic pathway approach to a complex disease: axon guidance and parkinson disease. PLoS Genet 3(6):e98CrossRef

Li B, Ruotti V, Stewart RM et al (2009) RNA-Seq gene expression estimation with read mapping uncertainty. Bioinformatics 26(4):493–500CrossRef

Li B, Zhang Y, Yu Y et al (2015) Quantitative assessment of gene expression network module-validation methods. Sci Rep 5:15258CrossRef

Liiv M, Cagalinec M, Hodurova Z, Vaarmann A, Mandel M, Zeb A, Kuum M, Hickey MA, Safiulina D, Choubey V et al (2015) Wolfram syndrome 1: from ER stress to impaired mitochondrial dynamics and neuronal development. SpringerPlus 4(1):P22CrossRef

Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15(12):550CrossRef

Mason MJ, Fan G, Plath K et al (2009) Signed weighted gene co-expression network analysis of transcriptional regulation in murine embryonic stem cells. BMC Genom 10(1):327CrossRef

Mason RR, Mokhtar R, Matzaris M, Selathurai A, Kowalski GM, Mokbel N, Meikle PJ, Bruce CR, Watt MJ (2014) PLIN5 deletion remodels intracellular lipid composition and causes insulin resistance in muscle. Mol Metab 3(6):652–663CrossRef

Medina IR, Lubovac-Pilav Z (2016) Gene co-expression network analysis for identifying modules and functionally enriched pathways in type 1 diabetes. PloS One 11(6):e0156006CrossRef

Michel TM, Käsbauer L, Gsell W, Jecel J, Sheldrick AJ, Cortese M, Nickl-Jockschat T, Grünblatt E, Riederer P (2014) Aldehyde dehydrogenase 2 in sporadic Parkinson’s disease. Parkinsonism Relat Dis 20:S68–S72CrossRef

Mitchell JC (1969) Social networks in urban situations: analyses of personal relationships in Central African towns. Manchester University Press, Manchester

Moran EP, Jx Ma (2015) Therapeutic effects of ppar\(\alpha\) on neuronal death and microvascular impairment. PPAR research 2015: https://doi.org/10.1155/2015/595426

Nam JH, Park ES, Won SY, Lee YA, Kim KI, Jeong JY, Baek JY, Cho EJ, Jin M, Chung YC et al (2015) TRPV1 on astrocytes rescues nigral dopamine neurons in Parkinson’s disease via CNTF. Brain 138(12):3610–3622CrossRef

Nuber S, Petrasch-Parwez E, Arias-Carrión O, Koch L, Kohl Z, Schneider J, Calaminus C, Dermietzel R, Samarina A, Boy J et al (2011) Olfactory neuron-specific expression of A30P alpha-synuclein exacerbates dopamine deficiency and hyperactivity in a novel conditional model of early Parkinson’s disease stages. Neurobiol Dis 44(2):192–204CrossRef

Nuytemans K, Theuns J, Cruts M, Van Broeckhoven C (2010) Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update. Hum Mutat 31(7):763–780CrossRef

O’Keeffe GW, Hegarty S, Sullivan A (2017) Targeting bone morphogenetic protein signalling in midbrain dopaminergic neurons as a therapeutic approach in Parkinson’s disease. Neuronal Signaling p NS20170027

Paisán-Ruız C, Jain S, Evans EW, Gilks WP, Simón J, Van Der Brug M, De Munain AL, Aparicio S, Gil AM, Khan N et al (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease. Neuron 44(4):595–600CrossRef

Park S, Choi SG, Yoo SM, Son JH, Jung YK (2014) Choline dehydrogenase interacts with SQSTM1/p62 to recruit LC3 and stimulate mitophagy. Autophagy 10(11):1906–1920CrossRef

Planken A, Kurvits L, Reimann E, Kadastik-Eerme L, Kingo K, Kõks S, Taba P (2017) Looking beyond the brain to improve the pathogenic understanding of Parkinson’s disease: implications of whole transcriptome profiling of Patients’ skin. BMC Neurol 17(1):6CrossRef

Riley BE, Gardai SJ, Emig-Agius D, Bessarabova M, Ivliev AE, Schüle B, Alexander J, Wallace W, Halliday GM, Langston JW et al (2014) Systems-based analyses of brain regions functionally impacted in Parkinson’s disease reveals underlying causal mechanisms. PloS One 9(8):e102909CrossRef

Robinson MD, Oshlack A (2010) A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol 11(3):R25CrossRef

Robinson MD, McCarthy DJ, Smyth GK (2010) edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26(1):139–140CrossRef

Ruipérez V, Darios F, Davletov B (2010) Alpha-synuclein, lipids and Parkinson’s disease. Prog Lipid Res 49(4):420–428CrossRef

Safran M, Dalah I, Alexander J, Rosen N, Iny Stein T, Shmoish M, Nativ N, Bahir I, Doniger T, Krug H, Sirota-Madi A, Olender T, Golan Y, Stelzer G, Harel A, Lancet D (2010) GeneCards Version 3: the human gene integrator. Database. https://doi.org/10.1093/database/baq020

Sahu A, Chowdhury HA et al (2020) Integrative network analysis identifies differential regulation of neuroimmune system in Schizophrenia and Bipolar disorder. Brain Behav Immun Health 2:100023CrossRef

Seale P, Conroe HM, Estall J, Kajimura S, Frontini A, Ishibashi J, Cohen P, Cinti S, Spiegelman BM (2011) PRDM16 determines the thermogenic program of subcutaneous white adipose tissue in mice. J Clin Investig 121(1):96–105CrossRef

Shi GX, Cai W, Andres DA (2013) RIT subfamily small GTPases: regulators in neuronal differentiation and survival. Cell Signal 25(10):2060–2068CrossRef

Singer GA, Lloyd AT, Huminiecki LB et al (2004) Clusters of co-expressed genes in mammalian genomes are conserved by natural selection. Mol Biol Evolut 22(3):767–775CrossRef

Soldner F, Stelzer Y, Shivalila CS, Abraham BJ, Latourelle JC, Barrasa MI, Goldmann J, Myers RH, Young RA, Jaenisch R (2016) Parkinson-associated risk variant in distal enhancer of \(\alpha\)-synuclein modulates target gene expression. Nature 533(7601):95CrossRef

Soreq L, Guffanti A, Salomonis N, Simchovitz A, Israel Z, Bergman H, Soreq H (2014) Long non-coding RNA and alternative splicing modulations in Parkinson’s leukocytes identified by RNA sequencing. PLoS Comput Biol 10(3):e1003517CrossRef

Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, Goedert M (1997) \(\alpha\)-Synuclein in Lewy bodies. Nature 388(6645):839CrossRef

Tesson BM, Breitling R, Jansen RC (2010) DiffCoEx: a simple and sensitive method to find differentially coexpressed gene modules. BMC Bioinform 11(1):497CrossRef

Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG et al (2004) Hereditary early-onset Parkinson’s disease caused by mutations in PINK1. Science 304(5674):1158–1160CrossRef

Van Duijn C, Dekker M, Bonifati V, Galjaard R, Houwing-Duistermaat J, Snijders P, Testers L, Breedveld G, Horstink M, Sandkuijl L et al (2001) PARK7, a novel locus for autosomal recessive early-onset Parkinsonism, on chromosome 1p36. Am J Hum Genet 69(3):629–634CrossRef

Watts DJ, Strogatz SH (1998) Collective dynamics of small-world networks. Nature 393(6684):440MATHCrossRef

Weinert BT, Timiras PS (2003) Invited review: theories of aging. J Appl Physiol 95(4):1706–1716CrossRef

Winklhofer KF, Haass C (2010) Mitochondrial dysfunction in Parkinson’s disease. Biochimica et Biophysica Acta (BBA)-Mol Basis Dis 1802(1):29–44

Woodard CM, Campos BA, Kuo SH, Nirenberg MJ, Nestor MW, Zimmer M, Mosharov EV, Sulzer D, Zhou H, Paull D et al (2014) iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson’s disease. Cell Rep 9(4):1173–1182CrossRef

Wu R, Xm Liu, Jg Sun, Chen H, Ma J, Dong M, Peng S, Jq Wang, Jq Ding, Li Dh et al (2017) DJ-1 maintains energy and glucose homeostasis by regulating the function of brown adipose tissue. Cell Dis 3:16054CrossRef

Xia R, Mao ZH (2012) Progression of motor symptoms in Parkinson’s disease. Neurosci Bull 28(1):39–48CrossRef

Zhao Z, Cao L, Reece EA (2017) Formation of neurodegenerative aggresome and death-inducing signaling complex in maternal diabetes-induced neural tube defects. Proc Nat Acad Sci 114(17):4489–4494CrossRef

Zwiener I, Frisch B, Binder H (2014) Transforming RNA-Seq data to improve the performance of prognostic gene signatures. PloS One 9(1):e85150CrossRef

Titel: Identification of potential Parkinson’s disease biomarkers using computational biology approaches
verfasst von: Hussain Ahmed Chowdhury
Pankaj Barah
Dhruba Kumar Bhattacharyya
Jugal Kumar Kalita
Publikationsdatum: 01.12.2021
Verlag: Springer Vienna
Erschienen in: Network Modeling Analysis in Health Informatics and Bioinformatics / Ausgabe 1/2021
Print ISSN: 2192-6662
Elektronische ISSN: 2192-6670
DOI: https://doi.org/10.1007/s13721-020-00280-5

Springer Professional

Abstract

Bitte loggen Sie sich ein, um Zugang zu Ihrer Lizenz zu erhalten.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Springer Professional "Technik"

Springer Professional "Wirtschaft"

Weitere Artikel der Ausgabe 1/2021

Comprehensive review of retinal blood vessel segmentation and classification techniques: intelligent solutions for green computing in medical images, current challenges, open issues, and knowledge gaps in fundus medical images

Telehealth and the digital divide as a social determinant of health during the COVID-19 pandemic

Repurposing natural compounds as potent inhibitors of β-catenin: an integrative in-silico approaches

Molecular docking and dynamics studies of curcumin with COVID-19 proteins

A compressive mathematical model including an eclipse stage of infected cells to study the impact of stem cells transplantation on one HIV1 patient

A novel ToCC map and two-level scrambling-based medical image encryption technique

Premium Partner